CLS Stock Recent News

CLS appears to be treading in the middle of the road and new investors could be better off if they trade with caution.

Innovative certified plastic-negative packaging partnership with AE Global's Talk Trash is projected to remove 27,000 lbs of ocean-bound plastic from the environment in 2025. Las Vegas, Nevada--(Newsfile Corp. - October 15, 2024) - CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH), (the ''Company'' or ''CLS''), a diversified cannabis company operating as Cannabis Life Sciences, is excited to announce a new partnership with AE Global's Talk Trash Initiative-a program focused on preventing ocean-bound plastic.

Celestica is expected to beat both revenue and earnings, driven by strong AI demand and favorable market conditions. Management's guidance and analysts' expectations suggest significant growth, with my estimates being even higher, particularly in the AI-driven CCS segment. The company is expanding capacity in Thailand and Malaysia, positioning itself well for future growth amid increasing AI CapEx spending.

I still believe that Celestica is one of the most undervalued and underlooked opportunities in the AI market today. The company's Q2 FY2024 results showed impressive year-on-year growth, with sales up 23% and EPS up 65.45%, indicating effective operating leverage. Celestica's financial health is robust, with a healthy balance sheet, improved inventory management, and strategic use of free cash flow for deleveraging and share buybacks.

CLS' overly expensive valuations have finally been brought closer to earth, thanks to the recent market rotation in July/ August 2024. With the two main players in AI still reporting robust performance metrics, we believe that CLS remains a compelling value buy, attributed to its cheap PEG non-GAAP ratio of 0.51x. Combined with the hyperscalers' intensified capex guidance in the near/ intermediate term, it is unsurprising that CLS is expected to generate robust top/ bottom line growth through FY2026.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Celestica Inc . (TSX: CLS) (NYSE: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world's most innovative companies, today launched its DS4100, a new 1U 800G per port top-of-rack, leaf/spine switch designed to address the high-bandwidth demands of AI/ML data center networking across enterprise, service provider and cloud provider domains.

Celestica Inc. (CLS, Financial) saw a significant stock price increase of 5.01%. The stock is currently trading at $58.50 per share with a trading volume of 1.23 million shares, a turnover rate of 1.04%, and a price fluctuation of 4.58%.

- Maintained Stable Visual Acuity and Anatomical Control Over 9 Months - - Positive Safety Profile with No Ocular or Treatment-Related Serious Adverse Events - - 67% of CLS-AX Participants Did Not Require Any Additional Treatment up to 6 Months - - Reduced Treatment Burden by 84% Over 6 Months - - Webcast and Conference Call Today at 8:00 A.M. ET with Management and  Key Opinion Leader and Board-Certified Retinal Specialist, Roger Goldberg, M.D.

Celestica stock is working on a five-day winning streak as it approaches its all-time high, which is also its buy point.